Silvia Mercuri

mTOR inhibition improves mitochondria function/biogenesis and delays cardiovascular aging in kidney transplant recipients with chronic graft dysfunction

N. Brunetti, L. Gesualdo, E. Ranieri, 2021, Aging.

Treatment of COVID-19 atypical pneumonia by early Tocilizumab administration in “non-critically-ill” patients on hemodialysis

L. Gesualdo, G. Stallone, B. Infante, 2020, Journal of Nephrology.

mTOR inhibitors improve both humoral and cellular response to SARS-CoV-2 messenger RNA BNT16b2 vaccine in kidney transplant recipients

L. Gesualdo, E. Ranieri, P. Pontrelli, 2022, American Journal of Transplantation.

Unraveling the Link between Interferon-α and Systemic Lupus Erythematosus: From the Molecular Mechanisms to Target Therapies

L. Gesualdo, E. Ranieri, P. Pontrelli, 2022, International journal of molecular sciences.

mTOR-inhibitors and post-transplant diabetes mellitus: a link still debated in kidney transplantation

L. Gesualdo, G. Stallone, G. Zaza, 2023, Frontiers in Medicine.

Hypoxic State of Cells and Immunosenescence: A Focus on the Role of the HIF Signaling Pathway

P. Pontrelli, G. Stallone, B. Infante, 2023, Biomedicines.